|
US4393066A
(en)
*
|
1981-06-05 |
1983-07-12 |
Garrett David M |
Method for treatment of herpetic lesions
|
|
US4499064A
(en)
*
|
1982-06-03 |
1985-02-12 |
Clayton Foundation For Research |
Assessment of nutritional status of individuals
|
|
US4575498A
(en)
*
|
1983-07-21 |
1986-03-11 |
Duke University |
Method for restoring depleted purine nucleotide pools
|
|
US4628052A
(en)
*
|
1985-05-28 |
1986-12-09 |
Peat Raymond F |
Pharmaceutical compositions containing dehydroepiandrosterone and other anesthetic steroids in the treatment of arthritis and other joint disabilities
|
|
CH673459A5
(https=)
*
|
1987-05-15 |
1990-03-15 |
Eprova Ag |
|
|
DE58902094D1
(de)
*
|
1988-01-28 |
1992-10-01 |
Koeltringer Peter |
Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
|
|
FR2631828B1
(fr)
*
|
1988-05-27 |
1994-05-20 |
Spiral Recherche Developpement |
Utilisation d'une substance folinique en tant qu'agent antiagregant plaquettaire
|
|
US4931441A
(en)
*
|
1988-11-09 |
1990-06-05 |
Luitpold Pharmaceuticals, Inc. |
Stabilized aqueous leucovorin calcium compositions
|
|
US4920115A
(en)
*
|
1988-12-28 |
1990-04-24 |
Virginia Commonwealth University |
Method of lowering LDL cholesterol in blood
|
|
US5407684A
(en)
*
|
1988-12-30 |
1995-04-18 |
Virginia Commonwealth University |
Use of DHEA as a medicinal
|
|
US5077284A
(en)
*
|
1988-12-30 |
1991-12-31 |
Loria Roger M |
Use of dehydroepiandrosterone to improve immune response
|
|
IT1229517B
(it)
*
|
1989-01-31 |
1991-09-03 |
Bioresearch Spa |
Impiego di acido 5-metiltetraidrofolico, di acido 5 formiltetraidrofolico, e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato adatte ad essere impiegate nella terapia dei disordini depressivi e composizioni farmaceutiche relative.
|
|
IT1229203B
(it)
*
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
NL8901432A
(nl)
*
|
1989-06-06 |
1991-01-02 |
Pharmachemie Bv |
Bij koelkasttemperatuur stabiele waterige folinaatoplossing, alsmede werkwijze ter bereiding daarvan.
|
|
US4985443A
(en)
*
|
1989-08-04 |
1991-01-15 |
Montes Leopoldo F |
Method and composition for treating vitiligo
|
|
US5173488A
(en)
*
|
1989-08-21 |
1992-12-22 |
American Cyanamid Company |
Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method
|
|
US5270305A
(en)
*
|
1989-09-08 |
1993-12-14 |
Glaxo Group Limited |
Medicaments
|
|
US5110810A
(en)
*
|
1991-02-08 |
1992-05-05 |
Virginia Commonwealth University |
Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of platelet aggregation
|
|
US5162198A
(en)
*
|
1991-02-08 |
1992-11-10 |
Virginia Commonwealth University |
Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of thrombuxane production and platelet aggregation
|
|
US5266312A
(en)
*
|
1992-01-07 |
1993-11-30 |
National Jewis Center For Immunology And Respiratory Medicine |
Method for treating a steroid resistant condition via administration of gamma interferon
|
|
ATE193447T1
(de)
*
|
1992-02-24 |
2000-06-15 |
Univ East Carolina |
Verfahren zur hemmung der karzinogenese durch behandlung mit dehydroepiandrosteron und dessen analoge
|
|
US6093706A
(en)
*
|
1992-03-04 |
2000-07-25 |
Bioresponse, L.L.C. |
Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
|
|
WO1993019747A1
(en)
*
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
|
JP3251587B2
(ja)
*
|
1992-04-02 |
2002-01-28 |
スミスクライン・ビーチャム・コーポレイション |
炎症疾患の治療および腫瘍壊死因子の産生阻害に有用な化合物
|
|
AU3738393A
(en)
*
|
1992-04-02 |
1993-11-08 |
Smithkline Beecham Corporation |
Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
|
|
US5552438A
(en)
*
|
1992-04-02 |
1996-09-03 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
|
US5922701A
(en)
*
|
1992-05-01 |
1999-07-13 |
University Of Utah Research Foundation |
Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
|
|
US5686438A
(en)
*
|
1993-03-09 |
1997-11-11 |
University Of Utah Research Foundation |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
|
|
SK286051B6
(sk)
*
|
1993-01-19 |
2008-02-05 |
Endorecherche Inc. |
Použitie prekurzora pohlavného steroidu na prípravu liečiva na prevenciu alebo liečenie znížených alebo nevyrovnaných koncentrácií pohlavných steroidov
|
|
US5811418A
(en)
*
|
1993-03-09 |
1998-09-22 |
University Of Utah Research Foundation |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
|
|
US5635496A
(en)
*
|
1993-03-09 |
1997-06-03 |
University Of Utah Research Foundation |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
|
|
US5846963A
(en)
*
|
1995-06-07 |
1998-12-08 |
University Of Utah Research Foundation |
Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
|
|
ATE283052T1
(de)
*
|
1993-03-09 |
2004-12-15 |
Univ Utah Res Found |
Verwendung von dhea oder dessen derivate zur herstellung eines medikaments zur vorbeugung von progressiver gewebe-nekrose, reperfusionsschädigung, bakterieller translokation und vom atemnotsyndrom bei erwachsenen
|
|
US5407927A
(en)
*
|
1993-04-16 |
1995-04-18 |
The Regents Of The University Of California |
Treatment of mild depression and restoration of IGF-I levels in aging by dehydroepiandrosterone
|
|
DE59410119D1
(de)
*
|
1993-07-02 |
2002-06-20 |
Byk Gulden Lomberg Chem Fab |
Fluoralkoxy substituierte benzamide und ihre verwendung als zyklisch-nukleotid phosphodiesterase-inhibitoren
|
|
EP0796112A4
(en)
*
|
1994-11-30 |
1999-12-01 |
Amur Research Corp |
MEDICINAL DERIVATIVES OF PHOSPHOCHOLIN
|
|
US20020032160A1
(en)
*
|
1995-02-24 |
2002-03-14 |
Nyce Jonathan W. |
Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
|
|
US5660835A
(en)
*
|
1995-02-24 |
1997-08-26 |
East Carolina University |
Method of treating adenosine depletion
|
|
US5859000A
(en)
*
|
1995-06-07 |
1999-01-12 |
University Of Utah Research Foundation |
Method for reducing mast cell mediated allergic reactions
|
|
US5767278A
(en)
*
|
1995-10-06 |
1998-06-16 |
Geron Corporation |
Telomerase inhibitors
|
|
EP1806131A3
(en)
*
|
1996-07-22 |
2007-08-01 |
Renovo Limited |
Use of sex steroid function modulators to treat wounds and fibrotic disorders
|
|
US5861391A
(en)
*
|
1997-01-29 |
1999-01-19 |
Research Development Foundation |
Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease
|
|
US20030013772A1
(en)
*
|
2000-02-23 |
2003-01-16 |
Murphy Michael A. |
Composition, synthesis and therapeutic applications of polyamines
|
|
AU763307B2
(en)
*
|
1998-02-04 |
2003-07-17 |
Charlotte-Mecklenburg Hospital Authority |
Androsterone derivatives for inhibiting DNA binding of AP-1 and airway smooth muscle proliferation
|
|
JP2003513038A
(ja)
*
|
1999-10-29 |
2003-04-08 |
スミスクライン・ビーチャム・コーポレイション |
ホスホジエステラーゼ４阻害剤の投与法
|
|
AR029189A1
(es)
*
|
1999-11-02 |
2003-06-18 |
Smithkline Beecham Corp |
Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
|
|
WO2001060358A1
(en)
*
|
2000-02-16 |
2001-08-23 |
University Of Nebraska Medical Center |
Method and compositions for treating fibrotic diseases
|
|
EP1161949A1
(en)
*
|
2000-06-09 |
2001-12-12 |
Warner-Lambert Company |
Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
|
|
US7381713B2
(en)
*
|
2000-12-04 |
2008-06-03 |
Sioan-Kettering Institute For Cancer Research |
Treatment of cancer by reduction of intracellular energy and pyrimidines
|
|
US20050070487A1
(en)
*
|
2001-04-24 |
2005-03-31 |
Nyce Jonathan W. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
WO2002085297A2
(en)
*
|
2001-04-24 |
2002-10-31 |
East Carolina University |
Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
|
|
US20030216329A1
(en)
*
|
2001-04-24 |
2003-11-20 |
Robinson Cynthia B. |
Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s)
|
|
GB0115181D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Glaxo Group Ltd |
Novel use
|
|
GB0118373D0
(en)
*
|
2001-07-27 |
2001-09-19 |
Glaxo Group Ltd |
Novel therapeutic method
|
|
US20030138434A1
(en)
*
|
2001-08-13 |
2003-07-24 |
Campbell Robert L. |
Agents for enhancing the immune response
|
|
GB0123951D0
(en)
*
|
2001-10-05 |
2001-11-28 |
Glaxo Group Ltd |
Therapies for treating respiratory diseases
|
|
FR2834212B1
(fr)
*
|
2001-12-27 |
2004-07-09 |
Besins Int Belgique |
Utilisation d'une poudre a liberation immediate dans des compositions pharmaceutiques et nutraceutiques
|
|
US20050026886A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
|